药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Trimethaphan
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Vandetanib.
Trimethaphan
Aripiprazole lauroxil
The risk or severity of QTc prolongation can be increased when Aripiprazole lauroxil is combined with Vandetanib.
Trimethaphan
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Vandetanib.
Trimethaphan
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Vandetanib.
Trimethaphan
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Vandetanib.
Trimethaphan
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Vandetanib.
Trimethaphan
Lorajmine
The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Vandetanib.
Trimethaphan
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Vandetanib.
Trimethaphan
Prajmaline
The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Vandetanib.
Trimethaphan
Bencyclane
The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Vandetanib.
Trimethaphan
Cibenzoline
The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Vandetanib.
Trimethaphan
Gallopamil
The risk or severity of QTc prolongation can be increased when Gallopamil is combined with Vandetanib.
Trimethaphan
Cicletanine
The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Vandetanib.
Trimethaphan
Pilsicainide
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Vandetanib.
Trimethaphan
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Vandetanib.
Trimethaphan
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Vandetanib.
Trimethaphan
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Vandetanib.
Trimethaphan
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Vandetanib.
Trimethaphan
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Vandetanib.
Trimethaphan
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Vandetanib.